ArticleFrontiers in systems biology2025
A model-based design strategy to engineer miRNA-regulated detection systems.
Article in Frontiers in systems biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
miRNAs are promising diagnostic biomarkers. These small RNA molecules are always present in the human body but become dysregulated when a person develops certain diseases. Although the detection of these biomarkers in cell-free tests is ongoing work, current systems often focus solely on detecting the presence or absence of a specific miRNA, rather than the miRNAs concentration. Thus, these tests may miss relative changes in miRNA concentration when disease-induced dysregulation occurs. This work, part of the WUR iGEM 2024 project (miRADAR), aimed to address this gap by incorporating an miRNA concentration-dependent threshold mechanism in a cell-free diagnostic test. In this system, continuous miRNA input concentrations need to be converted into a binary output signal, classifying the miRNA concentration as healthy (no output signal) or indicative of disease (strong output signal). To aid the experimental engineering of the test, here we use mathematical models to evaluate and assess different candidate networks. We apply a previously published multi-objective optimisation strategy to obtain designs that satisfy relevant constraints, such as low basal expression, high readout levels, and steep switching behaviour between low and high input miRNA concentrations. Models for three different biological mechanisms were compared based on their ability to generate the desired binary output signal. One approach used three-node protein networks (such as feed-forward loops), while the other two utilised RNA-based toehold systems. Overall, the toehold-mediated strand displacement systems demonstrated the most potential for experimental implementation. These systems are believed to be less burdensome in a cell-free environment, can be more readily engineered for new miRNA sequences, and showed high detection accuracy. Based on our results, we discuss how the inclusion of sequence-specific parameters could expand the design space of our mathematical models and how careful engineering of optimisation criteria is required to evaluate designs. Ultimately, our model-based study highlights that toehold-mediated strand displacement networks have the potential to be efficient miRNA detection systems for biosensing tools in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.